CE certification has been obtained more than 95%
Biokey Health Antigen Rapid Test Kit (Colloidal Gold)

[Materials Provided]

Reagents and Materials Provided

There are three kit sizes. Their kit component configurations are provided below:

[Storage and Stability]

• Store at 2~30ºC in the sealed pouch up to the expiration date printed on the package. Do not freeze.
• The test cassette should be used within 1 hour after taking out from the foil envelope. Buffer solution should be re-capped in time after use.
• Keep away from sunlight, moisture and heat.

4. Kit contents are stable until the expiration date printed on the outer box.

[Specimen]

Specimens obtained early during symptom onset will contain the highest viral titers; specimens obtained after five days of illness are more likely to be negative compared to an RT-PCR assay.

Inadequate specimen collection, improper specimen handling and/or transport may yield false results; therefore, training in

specimen collection is highly recommended due to the importance of specimen quality to obtain accurate test results. Acceptable specimen type for testing is a direct swab specimen or a swab in viral transport media (VTM) without denaturing agents.

Prepare the extraction tube according to the Test Procedure and use the sterile swab provided in the kit for specimen collection.

Bio key Health is a high-tech enterprise with integrating R&D, production and sales&marketing in Guangzhou. Since 2003. Bio Key was founded by the "Thousand Talents Program" entrepreneurial team and the overseas senior automation equipment development engineer team.

The company's core team has been in the field of IVD research and entrepreneurship for more than 10 years, and has mastered a wealth of molecular diagnostic POCT industrial application technology, SmartTRF immune detection technology, RT qPCR nucleic acid detection technology and independent research and development capabilities of instruments.

It has a number of independent core technologies in the fields of automation engineering, micro-precision manufacturing, immunofluorescence, nucleic acid detection and gene sequencing. Since its establishment, the company has applied for more than 60 patents and currently has 17 authorized patents. The company has two R&D centers for diagnostic reagents and instruments and equipment, totaling more than 500 square meters; it has established more than 2,000 square meters of GMP workshops and equipment production plants; it has SmartTRF new immune detection technology, nucleic acid detection technology (POCT) and three scientific services.